Mr. Bashar has served as a director since December 2015, and as the executive chairman of our board of directors since December 2016. Mr. Beshar has more than 35 years of financial and executive leadership experience. Until February 2015 Mr. Beshar was Executive Vice President and CFO of NPS Pharmaceuticals, Inc. sold to Shire plc in February 2015. Prior to joining NPS, Mr. Beshar served as Executive Vice President and Chief Financial Officer of Cambrex Corporation, a global life sciences company. Mr. Beshar is a certified public accountant. He obtained his bachelor's degree in Accounting and Finance from Michigan State University and is a graduate of The Executive Program at the Darden Graduate School of Business at the University of Virginia.
Dr. Garceau has served as director since March 2016 and as our Chief Development Advisor since December 2016. Dr. Garceau has more than 30 years of broad pharmaceutical industry experience. From December 2008 to February 2015 , Dr. Garceau was Executive Vice President and CMO of NPS Pharmaceuticals, Inc. sold to Shire plc in February 2015. From 2002 to December 2008, Dr. Garceau hold several senior leadership positions at Sanofi-Aventis. Previously, Dr. Garceau held various positions, including Vice President of clinical operations, interim head of North American medical and regulatory affairs, and head of U.S. medical research. Prior to Sanofi-Aventis, Dr. Garceau spent 16 years with Pharmacia Corporation. Dr. Garceau is a board-certified pediatrician. He received a bachelor of science in biology from Fairfield University in Fairfield, Connecticut and his doctorate of medicine from the University of Massachusetts Medical School. He is a Fellow of the American Academy of Pediatrics.